Cargando…
Immunocytometric analysis of patients with thymic epithelial tumors revealed that COVID-19 vaccine booster strongly enhanced the immune response
BACKGROUND: Thymic epithelial tumors (TETs) are rare malignancies with heterogeneous clinical manifestations. The high frequency of autoimmune paraneoplastic disorders observed in such patients requires caution when using COVID-19 vaccines. Furthermore, TETs are often associated with severe immunode...
Autores principales: | Cernera, Gustavo, Gelzo, Monica, De Placido, Pietro, Ottaviano, Margaret, Pietroluongo, Erica, Raia, Maddalena, Scalia, Giulia, Tortora, Marianna, Castaldo, Giuseppe, Formisano, Pietro, Palmieri, Giovannella, Giuliano, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495582/ https://www.ncbi.nlm.nih.gov/pubmed/37705978 http://dx.doi.org/10.3389/fimmu.2023.1233056 |
Ejemplares similares
-
The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug?
por: Montella, Liliana, et al.
Publicado: (2022) -
Immunological signature of patients with thymic epithelial tumors and Good syndrome
por: Malfitano, Anna Maria, et al.
Publicado: (2022) -
Immunocytometric analysis of COVID patients: A contribution to personalized therapy?
por: Cacciapuoti, Sara, et al.
Publicado: (2020) -
Impaired seroconversion after SARS-CoV-2 mRNA vaccine in patients with thymic epithelial tumors
por: Pietroluongo, Erica, et al.
Publicado: (2023) -
Shifting from a Biological-Agnostic Approach to a Molecular-Driven Strategy in Rare Cancers: Ewing Sarcoma Archetype
por: Caltavituro, Aldo, et al.
Publicado: (2023)